Article Information
History
- May 8, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Alexander Gusev*,1,2,†,
- Sandor Spisak*,1,3,
- Andre P. Fay4,5,
- Hallie Carol1,
- Kevin C Vavra6,7,
- Sabina Signoretti1,
- Viktoria Tisza1,8,
- Mark Pomerantz1,3,
- Forough Abbasi6,
- Ji-Heui Seo1,3,
- Toni K. Choueiri1,
- Kate Lawrenson6,7 and
- Matthew L Freedman1,3
- 1Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA
- 2Division of Genetics, Brigham & Women’s Hospital, Boston, MA
- 3Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA
- 4Latin American Cooperative Oncology Group, Partenon, Porto Alegre, Brazil
- 5PUCRS School of Medicine, Porto Alegre, RS, Brazil
- 6Department of Obstetrics and Gynecology and the Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 7Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 8Computational Health Informatics Program (CHIP) Boston Children’s Hospital Harvard Medical School, Boston, MA 02215, USA
- ↵† Corresponding author; email: alexander_gusev{at}dfci.harvard.edu
↵* Equal contribution